4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-25-120105
Chief Scientific Officer sold 202,908 shares at an average $14.85 ($3,012,462)
From the SEC's structured data for this filing
Trades in this filing
Reich Kristian · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-08 | Sale : show line 1 in the form | −130,000 | $15.08 | $1,960,400 | 72,908 | D |
| 2025-12-09 | Sale : show line 2 in the form | −72,908 | $14.43 | $1,052,062 | 0 | D |
| Open-market sales · 202,908 sh · avg $14.85 · $3,012,462 | ||||||
Loading xslF345X05/ownership.xml…